Clinical

Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.


Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP Technology. Click here to start the conversation now.

Learn More

Luminex Blog

The Faces of Luminex: Robin Murphy, Systems Integration

The Luminex R&D teams for hardware, software, reagents, and assays operate mostly independently—which means we need great scientists to pull each of these elements together and ensure a seamless user experience. For this, we rely on Robin Murphy, Scientist II, who has been part of our family since 2006.

Continue Reading >

xMAP Technology

 
Video Thumbnail
Luminex xMAP® Technology Overview
Clinical Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.Read More Research Our xMAP® Technology and its flexibl

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


Mahmoud Elsabahy of @TAMU uses #xMAP technology to trace the biomarker response to nanomedicines and nanocarriers.… https://t.co/XWZJI2tOje
h J R
Interested in learning about Luminex’s history? Want to know what we are doing today? Check out the recent Austin U… https://t.co/U8BMfb5ibd
h J R
The first U.S. case of coronavirus has been confirmed by the @CDCgov. #health #disease #biotech # #publichealth… https://t.co/Wst0nRe9vT
h J R